We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
508 hedge funds and large institutions have $10.1B invested in United Therapeutics in 2023 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 173 increasing their positions, 181 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
112% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 34
29% more funds holding in top 10
Funds holding in top 10: 14 → 18 (+4)
7% more funds holding
Funds holding: 475 → 508 (+33)
1% more capital invested
Capital invested by funds: $9.94B → $10.1B (+$119M)
4% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 181
1.4% less ownership
Funds ownership: 96.18% → 94.78% (-1.4%)
29% less call options, than puts
Call options by funds: $25.6M | Put options by funds: $36M
Holders
508
Holders Change
+33
Holders Change %
+6.95%
% of All Funds
8.06%
Holding in Top 10
18
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+28.57%
% of All Funds
0.29%
New
72
Increased
173
Reduced
181
Closed
34
Calls
$25.6M
Puts
$36M
Net Calls
-$10.5M
Net Calls Change
-$15.6M
Top Buyers
| 1 |
Comerica Bank
Dallas,
Texas
|
+$34.8M |
| 2 |
Millennium Management
New York
|
+$26.8M |
| 3 |
NC
Nitorum Capital
New York
|
+$25.7M |
| 4 |
Amundi
Paris,
France
|
+$20.3M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$15.9M |
